Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC |
Hayes TimothyDirector
|
GrantClass A Common Stock | 128,474 | $0.62 | $79,653.88 |
DisclosureSEC source: 0001213900-25-057985 · ownership.xml · nonDerivative · entry 1 Hayes Timothy · CIK 0002020283 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,474 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC |
Howard William D.Director
|
GrantClass A Common Stock | 128,474 | $0.62 | $79,653.88 |
DisclosureSEC source: 0001213900-25-057986 · ownership.xml · nonDerivative · entry 1 Howard William D. · CIK 0001993318 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,474 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC |
Shrestha Sanjay KDirector
|
GrantClass A Common Stock | 128,474 | $0.62 | $79,653.88 |
DisclosureSEC source: 0001213900-25-057984 · ownership.xml · nonDerivative · entry 1 Shrestha Sanjay K · CIK 0001775802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,474 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on April 8, 2025, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since April 8, 2025 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| June 23, 2025 Filed Jun 26, 2025 01:00 UTC |
Umemezia ChikeDirector
|
GrantClass A Common Stock | 128,474 | $0.62 | $79,653.88 |
DisclosureSEC source: 0001213900-25-057983 · ownership.xml · nonDerivative · entry 1 Umemezia Chike · CIK 0001994472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,474 F1 · shares: Represent restricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. The shares of restricted stock vest either (i) fully upon one year of service commencing on December 23, 2024, or (ii), if not vested upon such date, partially vest at the first shareholders' meeting, with the number of vested shares determined by multiplying the total number of restricted stock by a ratio with the numerator being the lesser of the period of time since December 23, 2024 and 12 months and the denominator being 12 months, subject to the reporting person's continuous service through the vesting date. Read SEC document |
| March 25, 2025 Filed Mar 27, 2025 20:31 UTC |
Plantholt DustinChief Growth Officer
|
GrantClass A Common Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001013762-25-003408 · ownership.xml · nonDerivative · entry 1 Plantholt Dustin · CIK 0002062449 · Chief Growth Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 F1 · shares: Represent unrestricted shares of Class A Common Stock granted to the reporting person pursuant to the Health in Tech Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.